By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Allergan Inc. 

2525 Dupont Drive

Irvine  California  92612  U.S.A.
Phone: 714-246-4500 Fax: n/a


SEARCH JOBS

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments to help people reach their life’s potential. Today, we have approximately 11,100 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully. For the year ending 2012, our total product net sales totaled $5.5 billion, a 10 percent increase over 2011. From our beginnings as an eye care company to our focus today on several medical specialties, including eye care, neurosciences, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention and urologics, Allergan is proud to celebrate more than six decades of medical advances and proud to support the patients and physicians who rely on our products and the employees and communities in which we live and work. For more information regarding Allergan, go to: www.allergan.com.


Key Statistics


Email: Corpinfo@allergan.com
Ownership: Public

Web Site: Allergan Inc.
Employees: 11,100
Symbol: AGN
 



Industry
Pharmaceutical


Collaborations

Elan Pharmaceuticals 

CeNes Pharmaceuticals (U.S.) 

PanVera LLC 

Pharmagene Laboratories Limited  Phase ZERO(TM) products and services.

ACADIA Pharmaceuticals, Inc.  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

ACADIA Pharmaceuticals, Inc.  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

ACADIA Pharmaceuticals, Inc.  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.





Company News
Allergan Inc. (AGN) To Request California Federal Court Block Valeant Pharmaceuticals International (VRX) And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws 8/27/2014 9:51:47 AM
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014 6:08:18 AM
Pershing Square Submits Requisite Requests From Allergan Inc. (AGN) Shareholders To Call Special Meeting 8/25/2014 10:26:35 AM
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid 8/22/2014 5:51:47 AM
Allergan Inc. (AGN) Approaches Salix Pharmaceuticals, Ltd. (SLXP) To Fend Off Valeant Pharmaceuticals International (VRX)'s Hostile Bid 8/20/2014 6:27:57 AM
Allergan Inc. (AGN) Release: Nearly Half Of Women In New Survey Reveal That Their Current Treatments Are Not Adequately Addressing Overactive Bladder (OAB) Symptoms 8/19/2014 7:50:38 AM
Allergan Inc. (AGN) CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International (VRX) 8/19/2014 5:58:36 AM
Allergan Inc. (AGN) Names Jim Hindman Chief Financial Officer 8/18/2014 9:37:43 AM
Valeant Pharmaceuticals International (VRX) Extends Offer To Acquire Allergan Inc. (AGN) 8/18/2014 8:08:00 AM
SEC Investigating Valeant Pharmaceuticals International (VRX), Pershing Square's Hostile Takeover Bid For Allergan Inc. (AGN) 8/15/2014 6:30:34 AM
12345678910...
//-->